Pharmacology & Dosage Calculation
The nurse cares for a 60 year old woman who has a history of hypertension, hypothyroidism and elevated…
The nurse cares for a 60 year old woman who has a history of hypertension, hypothyroidism and elevated cholesterol levels. She takes tablets daily for each of the health problems. The doctor orders a routine dual-x-ray absorptiometry test that shows decreased bone density. Which medication most likely contributed to the test result?
Explanation
Core Concept: Synthetic thyroid hormones (e.g., levothyroxine) are used to treat hypothyroidism. However, iatrogenic hyperthyroidism (over-replacement or supraphysiologic doses) increases bone turnover by stimulating osteoclast activity more than osteoblast activity. This leads to a net loss of bone mineral density, increasing the risk of osteopenia and osteoporosis, particularly in postmenopausal women.
Clinical Presentation:
- Osteoporosis is typically asymptomatic until a fragility fracture occurs (e.g., wrist, hip, or vertebral compression fractures).
- Signs of over-replacement (hyperthyroidism) include palpitations, weight loss, heat intolerance, tremors, and anxiety.
- Complications include loss of height, kyphosis, chronic pain, and severe morbidity/mortality from hip fractures.
Diagnosis:
- First-line diagnostic tool: Dual-energy X-ray absorptiometry (DEXA) scan to measure bone mineral density (BMD) and calculate a T-score.
- Gold standard diagnostic test: Serum TSH and Free T4 levels to evaluate if the patient is on an excessive dose of thyroid hormone replacement.
Management:
- Acute management: Adjusting and lowering the dose of the synthetic thyroid hormone to achieve a euthyroid state (normal TSH) without causing hypothyroid symptoms.
- Gold standard long-term/definitive management: Treatment of osteoporosis with bisphosphonates (e.g., alendronate), RANKL inhibitors (denosumab), or anabolic agents (teriparatide), combined with adequate calcium and Vitamin D supplementation and weight-bearing exercises.